Health News (Reuters)

Aldi stores in Germany stop selling eggs amid Dutch food safety scare

FRANKFURT (Reuters) - Discount supermarket chain Aldi, which has more than 4,000 stores in Germany, said on Friday it was pulling all eggs from store shelves in the country as a precaution after a scare over the possible contamination of eggs from the Netherlands.

Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals

(Reuters) - The largest U.S. retail pharmacies, including Wal-Mart Stores Inc and Walgreens Boots Alliance Inc, are wielding more leverage when buying generic drugs, accelerating a decline in prices likely to affect drug companies for some time, industry experts said on Thursday.

Bristol-Myers to buy IFM Therapeutics to strengthen cancer pipeline

(Reuters) - Bristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million, as the drugmaker looks to bolster its cancer portfolio after losing ground to Merck & Co's rival treatment Keytruda.

Health insurer Aetna profit rises as Obamacare business shrinks

(Reuters) - Aetna Inc reported a higher-than-expected quarterly profit on Thursday as member health costs were lower than anticipated and it benefited from exiting most of its Obamacare individual insurance markets this year.

FDA approves AbbVie's hepatitis C drug

(Reuters) - The U.S. Food and Drug Administration on Thursday approved AbbVie Inc's drug to treat certain adults with chronic hepatitis C.

Shire may spin off hyperactivity drugs, raises forecasts

LONDON (Reuters) - Shire, the London-listed pharmaceutical firm built up by acquisitions, said it might spin off its hyperactivity drugs business into a separate company and focus solely on rare disease treatments.

Regeneron beats profit estimates, lifts Eylea's growth view

(Reuters) - Regeneron Pharmaceuticals Inc's quarterly profit handsomely beat estimates on strong demand for its flagship Eylea drug, helping the U.S. drugmaker raise its full-year growth forecast for the eye treatment.

Hansa Medical drug allows kidney transplantation in tough cases

LONDON (Reuters) - An experimental drug from Sweden's Hansa Medical has allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection, researchers said on Wednesday.

FDA panel votes against approval of J&J arthritis drug

(Reuters) - The benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.

Face-to-face therapy best to treat binge eating disorder

(Reuters Health) - - People should opt for face-to-face cognitive behavioral therapy if they're looking for the fastest way to address their binge eating disorder, suggests a new study from Germany.

Can a drink a day keep diabetes away?

(Reuters Health) - - People who enjoy one beer or glass of wine several days a week may be less likely to develop diabetes than drinkers who tend to have all their cocktails on a Saturday night, a Danish study suggests.

U.S. scientists able to alter genes of human embryos

U.S. scientists have succeeded in altering the genes of a human embryo to correct a disease-causing mutation, making it possible to prevent the defect from being passed on to future generations.

U.S. launches opioid fraud and detection unit

(Reuters) - U.S. Attorney General Jeff Sessions unveiled on Wednesday a plan to go after doctors and pharmacies suspected of healthcare fraud by over-prescribing and unbridled distribution of addictive pain medications known as opioids.